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ABSTRACT
Background Economic evaluation of public policies
has been advocated but rarely performed. Studies from a
systematic review of the health impacts of housing
improvement included data on costs and some economic
analysis. Examination of these data provides an
opportunity to explore the difﬁculties and the potential
for economic evaluation of housing.
Methods Data were extracted from all studies included
in the systematic review of housing improvement which
had reported costs and economic analysis (n=29/45).
The reported data were assessed for their suitability to
economic evaluation. Where an economic analysis was
reported the analysis was described according to pre-set
deﬁnitions of various types of economic analysis used in
the ﬁeld of health economics.
Results 25 studies reported cost data on the
intervention and/or beneﬁts to the recipients. Of these,
11 studies reported data which was considered
amenable to economic evaluation. A further four studies
reported conducting an economic evaluation. Three of
these studies presented a hybrid ‘balance sheet’
approach and indicated a net economic beneﬁt
associated with the intervention. One cost-effectiveness
evaluation was identiﬁed but the data were unclearly
reported; the cost-effectiveness plane suggested that the
intervention was more costly and less effective than the
status quo.
Conclusions Future studies planning an economic
evaluation need to (i) make best use of available data
and (ii) ensure that all relevant data are collected. To
facilitate this, economic evaluations should be planned
alongside the intervention with input from health
economists from the outset of the study. When
undertaken appropriately, economic evaluation provides
the potential to make signiﬁcant contributions to
housing policy.
INTRODUCTION
Economic evaluation of health technologies (drugs,
devices, etc) has become widespread across the
world, with government agencies (eg, National
Institute of Clinical Excellence (NICE) in England
and Wales) employing these techniques on a
routine basis to make decisions about which health-
care to fund.1–4 But there has been very little pro-
gress in economic evaluation for public health and
in particular within public policy.5–8 In 2005, the
remit for NICE was expanded to include public
health, reﬂecting a growing desire to broaden the
scope of such evaluations and address issues of
resource allocation across all sectors impacting on
health.9 10
Provision of acceptable housing conditions may
be regarded as a cornerstone of healthy public
policy, representing a major public investment with
the potential to improve health and contribute
wider public health strategies to improve popula-
tion health and reduce health inequalities.11–13 In
2009, a systematic review of the health impact of
housing interventions, including studies from
around the world, concluded that housing improve-
ments can lead to health improvements.14 This was
especially the case for warmth improvements tar-
geted at those with poor health, living in poor
housing. Some of the studies in the 2009 systematic
review included reports on the costs associated
with the interventions and a small number reported
having undertaken economic evaluations.14 Given
the growing desire of policy makers to demonstrate
value for money from interventions, we undertook
a further review of these studies to identify and
extract data which could be used to inform esti-
mates of the relative costs and beneﬁts of housing
improvement, and illustrate the challenges of eco-
nomic evaluation in this ﬁeld.
This paper presents the results of this review,
providing details of the cost and economic analyses
reported alongside housing intervention studies
and accompanying health impacts. The paper uses
these data to examine the economics of housing
investment and also to reﬂect on the current state
of health economic analysis in housing. As an
example of health economic evaluation of a sub-
stantial public investment and policy area, the
lessons may have a wider methodological relevance
to topics of interest to healthy public policy, such
as welfare reforms or transport initiatives.
METHODS
Prior to detailing the process undertaken for this
systematic review of economic data and analysis,
we detail the deﬁnitions used to distinguish
between differing types of cost studies and eco-
nomic evaluations (table 1). These deﬁnitions are
routinely applied in the ﬁeld of health economics
and have been proposed for the economic appraisal
of public health interventions.4 5 7 15
Cost studies
Table 1 details three forms of cost study which are
common within the literature, namely cost-offset,
cost-minimisation and cost-consequence. Cost-offset
studies simply detail the costs of the intervention
alongside the cost savings achievable (eg, days in
hospital averted). There is no measurement of
health outcome. Cost-minimisation studies compare
the costs (including any cost savings) for an inter-
vention with the costs of the status quo under the
assumption that the outcomes are equivalent
between the two. Cost-consequence studies present
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the costs (including any cost savings) associated with an interven-
tion and the status quo alongside a list of the various possible
outcomes achieved. There is no attempt to identify or value the
collective outcomes within a single metric. As such, while cost
consequence studies provide a useful descriptive summary, and
ﬁrst step towards a full economic evaluation, they cannot be used
to determine value for money or identify priority interventions.
These approaches are not formally economic evaluation tech-
niques because they do not allow for a formal comparative ana-
lysis in terms of costs and outcomes. In a situation where policy
involves the provision of a speciﬁc amenity (eg, a new heating/
insulation system) then a comparison of costs is all that is
required to establish the least costly way to provide the desired
amenity. However, this assumes that provision of the speciﬁc
amenity is, by some deﬁnition, a good thing (eg, it improves
health outcomes).
Economic evaluations
Where budgets are constrained there is an unavoidable oppor-
tunity cost of undertaking any policy, as funds spent on one
intervention will limit the funds available for other interven-
tions. The aim of economic evaluation is to assist policy makers
to identify interventions/policies which represent good value for
money. The value for money associated with a new intervention
is determined by comparing the additional costs required and
additional outcomes achieved, with the status quo or current
intervention. Where an intervention/policy provides greater out-
comes at lower costs, it is said to ‘dominate’ the current inter-
vention/policy and a decision about adopting the new
intervention/policy is straightforward. However, where an inter-
vention/policy provides greater outcomes at greater cost, a deci-
sion must be made about whether to spend these additional
resources to achieve these additional outcomes. Where
Table 1 Types of economic studies (an assessment of cost is common to all study types detailed)5 7 15
Type of economic
study Description Outcomes Further explanation
Cost-offset study Presents the costs (incurred and saved) associated
with the policy change
Not measured No consideration of health outcomes
Cost-minimisation
analysis
Presents the costs (incurred and saved) associated
with the policy change compared to the status quo
Assumed equal Involves the assumption that the outcomes associated
with the new policy are equivalent to those associated
with the status quo, thus it is sufficient to compare the
costs of the two to identify the least costly way of
achieving the outcome. It must be noted that true
equivalence of outcomes is rare and cost-minimisation
analysis is often used inappropriately
Cost-consequences
analysis
Presents a detailed listing of the various impacts on
outcomes associated with the policy change with no
attempt to value the aggregated components in a
single metric
Range of outcomes listed A useful first step towards economic evaluation. No
attempt to combine or simplify outcomes into a single
measure of effectiveness. Unless all of the individual
outcome components move in the same direction, in
order to determine whether a policy is worthwhile, it
will be necessary to aggregate the various components
and, with cost-consequences analyses, the burden for
this will fall on the policy maker, who must decide the
weightings associated with each component.
Cost-effectiveness
analysis
Presents the outcomes associated with the policy
change, and the status quo, in terms of
uni-dimensional health or clinical units. The additional
costs associated with the policy change are then
presented in terms of a cost-effectiveness ratio, as, for
example, the additional cost per additional asthma
attack averted
Measured in health units (eg,
asthma attacks, mental health
score, physical health score)
Cost-effectiveness analysis requires that there is a
single measure of outcome that captures the impacts
of the policy. The main issue for cost-effectiveness
analysis is that it can only be used to compare policies
that generate the same outcomes. For example, it
would not be possible to compare the
cost-effectiveness of a housing intervention for which
the outcome is measured as asthma attacks averted,
with an intervention for which the outcome is
measured as change in mental health score
Cost-utility analysis Special case of cost-effectiveness analysis where the
outcomes are presented as utility values. The
additional costs associated with the policy change are
presented in terms of a cost-utility ratio (often referred
to as the cost-effectiveness ratio), as, for example, the
additional cost per QALY
Measured as utility score
reflecting both the health
outcomes and preferences for
them (eg, QALY)
Cost-utility analyses can be used to compare policy
changes in different areas, with different natural
outcomes, by providing a common measure of
outcome. The most commonly used measure of utility
is the QALY which incorporates measures of the
quantity of life with assessments of the quality of life.
The main issue for cost-utility analysis is that it may
not capture the broader non-heath consequences
associated with the policy
Cost-benefit analysis Presents the outcomes associated with the policy
change, and the status quo, in monetary units. The
monetary value of the outcomes is then simply
compared to the costs; any policy change where the
monetary value of the outcomes outweighs the costs
is therefore considered worthwhile
Measured in monetary terms Cost- benefit analysis can be used to compare policy
changes in different areas. Outcomes not limited to
health consequences, will include all outcomes
associated with the policy that are of importance to
the individual. It is important to note that the term
‘cost-benefit analysis‘ is frequently misused to
represent economic evaluation in general or cost-offset,
cost-minimisation or cost-effectiveness analysis
QALY, quality adjusted life year.
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outcomes of different interventions/policies are valued using
common metrics (see table 1), the value for money associated
with them can be directly compared to indicate where these out-
comes can be achieved at the lowest price. These interventions
represent the best value for money compared with the alterna-
tives available and, where resources are scarce, could be consid-
ered ‘economically worthwhile’.
There are three main forms of economic evaluation: cost-
effectiveness analysis, cost-utility analysis and cost-beneﬁt ana-
lysis (table 1). Each method involves a ‘comparative analysis of
alternative courses of action in terms of both their costs and
consequences’.4 With each method costs are measured in monet-
ary units, while the measurement and valuation of outcomes
differs. As such, the methods are traditionally classiﬁed by
outcome.15
Cost-effectiveness analysis typically involves measuring a spe-
ciﬁc, one-dimensional, health or clinical outcome, for example
asthma attacks averted. Cost-utility analysis is a special type of
cost-effectiveness where multidimensional health outcomes are
reduced to a single dimension reﬂecting individuals’ preferences
for the diverse health outcomes. The most commonly used
outcome in cost-utility analysis is the quality adjusted life year
(QALY). For both cost-effectiveness and cost-utility studies,
value for money is identiﬁed using a measure of the additional
cost per additional outcome ratio (eg, an incremental cost/QALY
ratio) and comparing that to an external threshold or to the
ratio achieved by alternative policies. In contrast, cost-beneﬁt
analysis involves the measurement and valuation of all outcomes
of interest in monetary terms. Here the value for money is iden-
tiﬁed by positive net economic beneﬁt associated with the inter-
ventions (ie, the monetary value of the outcomes exceeds the
net costs of the intervention less any costs savings achieved else-
where). This Paretian deﬁnition of cost-beneﬁt analysis is the
established, standard deﬁnition used within health economics. It
allows a broad spectrum of outcomes (all those of importance
to the individual) to be included within the metric, but requires
the, often complex, valuation of outcomes in monetary terms.
Data extraction and analysis of economic data in housing
intervention studies
All housing intervention studies and their associated papers
included in the 2009 systematic review of the health impacts of
housing improvement14 were examined for reports of costs and
economic analyses. Details of the scope of the review (inclusion
and exclusion criteria), and evidence appraisal are available in
the 2009 publication along with the ﬁndings of the review.14
Forty-ﬁve medical and social science databases, as well as web-
sites and grey literature were searched to identify studies of
housing improvement which assessed change in any health
outcome. A separate search for economic studies was not under-
taken but economic studies which included health outcomes fol-
lowing housing improvement would have been identiﬁed in the
broad search. Two independent reviewers screened 27 082 cita-
tions to select the included studies. All available data on costs
and, where available, details of any economic analysis were
extracted by one reviewer (CM) and checked by a second
reviewer (EF or HT). The cost data were tabulated alongside a
summary of reported heath impacts and an indication of overall
study quality as used in the original review (A=minimal bias,
B=some bias, C=considerable bias).14 Where a study reported
plans to undertake economic analysis, the authors were con-
tacted for an update on progress and available data, or reasons
for not completing the economic analysis.
Studies were allocated into two groups based on the type of
data reported. Studies which only presented cost data (table 2)
were further examined for the potential to have conducted an
economic evaluation, that is, presence of a suitable health
outcome which could be linked to cost and compared to an
alternative (table 1). Studies which reported having undertaken
an economic evaluation (table 3) were examined to determine
the precise form of that analysis (table 1).
RESULTS
Forty-ﬁve studies were identiﬁed in the original review. The
study designs varied and included ﬁve randomised controlled
trials (RCTs), and 23 non-randomised controlled studies. The
better quality RCTs and controlled studies were used to draw
conclusions about effectiveness. The health outcomes reported
included validated measures, for example SF-36, and self-
reported measures, and covered four main domains: general
health; mental health; respiratory health; and other/illness and
symptoms. Twenty-nine studies reported costs or an economic
analysis; 25 of these studies16–41 presented only basic cost data
(table 2) while four studies reported having undertaken an eco-
nomic analysis (table 3).42–46
Studies which present cost data without economic
evaluation
Details of the 25 studies reporting cost data without economic
analysis are presented in table 2 (see supplementary table 1 for
full details of interventions, economic data and health impacts).
Eleven of the studies examined warmth and energy efﬁciency
interventions,16–26 eight examined rehousing or retroﬁtting,27–35
two focused on pre-1965 rehousing from slums40 41 and four
focused on provision of basic housing needs.36–39 Over 75% of
the studies (n=19) were from the UK,17–35 41 with one study
each from New Zealand,16 the USA,40 Mexico,36 Philippines,37
Pakistan38 and Malawi.39 The study design and methodological
quality of the studies varied, as assessed by the original systematic
review criteria. These studies reported a diverse range of health
outcomes, and the reported impacts suggest either improvement
or no change in health status following housing improvement
during the study period (see supplementary table 1). One study
reported a deteriorated health status following housing
improvement.22
Six studies24 26 33 40 47 48 presented data on both the cost of
providing the intervention and other costs, including those
incurred by the recipient, nine16 23 28 30 34–36 39 49 presented
only costs relating to the provision of the intervention and ten
studies18–19 25 27 29 31 37 38 41 presented only other costs, primar-
ily to the recipient. The cost measures used varied and require
different interpretations. For example, some studies reported
intervention costs of a major housing led regeneration pro-
gramme for an area beyond the included study population, while
other studies reported average costs of the speciﬁc housing inter-
vention per household. Measures used for recipient costs did not
always report direct data and some studies used residents’ assess-
ments of these changes, for example changes in fuel consumption
or bills, making it difﬁcult to interpret. The measures of other
costs to recipients were reported, nine studies reported changes
in fuel use or costs,17 19 25–27 31 38 47 48 six changes in
rent,17 26 27 31 40 41 three changes in healthcare spending,24 33 38
two changes in household costs17 29 and one changes in
income.37 One study compared the ability to manage ﬁnancially
between the intervention and control group.18 Drawing on the
most commonly reported recipient costs, all six studies which
reported numerical data for changes in fuel costs reported a
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Table 2 Summary of housing improvement studies reporting cost data without economic evaluation (ordered by intervention type, study quality and date)
Author, date, location
Study
quality
Study
design
Intervention
costs
Costs to
recipient
Potential for
economic evaluation Summary of economic data and accompanying authors’ interpretation
Intervention: Warmth and energy efficiency improvements (post-1980)
Howden-Chapman et al,
2008, New Zealand16
A RCT ✓ Yes Mean cost of intervention per house $(NZ)3000.
Platt et al, 2007, UK18 A Contr’d
B&A
✓ No Intervention group in receipt of improve heating were less likely to report difficulties to ‘manage financially’, than
those who did not acquire heating (OR: 0.77, 95% CI: 0.60 to 0.99).
Heyman et al, 2011,
UK47 56 57
B RCT ✓ ✓ Yes: SF-36 amenable
to QALY calculation
Mean cost of intervention per house £727. Mean fuel expenditure (Int/Cont n=99/83) £596/£567, p=0.408.
Change mean warmth satisfaction score (4 point scale) Int/Cont (n∼96/82) +1.18/+0.64
Lloyd et al, 2008, UK17 B Contr’d
B&A
✓ No Heating costs per week Before vs After (>4 years after intervention) (Int/Cont n=75/40) £35 vs £7 per week, no
change in rent. Control group do not report any changes in housing costs (unclear how data were obtained).
Shortt et al, 2007, UK19 58 59 B Contr’d
B&A
✓ No Fuel costs per annum Before vs After (Int n=54) £1113 vs £751.56. (Data refers to sub-group who received full
intervention, no data for changes in control group).
Warm Front Study Group,
2006, UK21 48 60–63
C Contr’d
B&A
✓ ✓ Yes Maximum value of grant per house £2500. Following introduction of cavity wall and loft insulation space heating
fuel consumption reduced by 10% in centrally heated properties and 17% in non-centrally heated properties. Gas
central heating system did not change fuel consumption due to increased internal temperature.
Allen, 2005, UK22 49 C UBA ✓ Yes Mean cost of intervention per house £4477 (range £799–£10 144), total cost of project £176 297.
Total funding from various grants (mean award per eligible property): disabled facilities £66 173 (£5494);
occupational therapy £1691 (£85); renovation grant £14 081; home repair grant £8811.
Allen, 2005, UK23 C UBA ✓ Yes Mean cost of intervention per house £5800 (range £350 to £14 000).
Eick et al, 2004, UK24 C RCT ✓ ✓ No Change in health costs in 3 months since intervention (n=16): GP visit −£136; GP home visit −£22.58; outpatient
visit −£220; hospital admission −£5740; steroids −£5.70; antibiotics −£16.80; nebuliser −£1.23; absence from
school due to asthma –£478.42; absence from school due to other reasons +£62.95Expenditure associated with
the installation of MVHR system: cost of unit and installation £2500; annual maintenance by owner £150; annual
running costs for occupant £35.
Caldwell et al, 2001, UK25 C Contr’d
B&A
✓ No Changes in annual energy costs since intervention (participant recall) in four intervention sites −£235.46/−
£457.70/−£206.47/−£254.60. No change reported in control sites
Green et al, 1999, UK26 64 C RC ✓ ✓ Yes Mean cost of intervention per house £28 000.
Estimated heating bills Int/Cont £4.46 vs £9.04 (difference in fuel costs attributed largely to differences in fuel
supplier tariffs rather than consumption); weekly rent Int/Cont £29.64/£19.63
Intervention: Rehousing/retrofitting ± neighbourhood renewal (post 1995)
Thomson et al, 2007, UK27 A Contr’d
B&A
✓ No Rent data presented for 33 (Int/Cont 18/15) participants. Mean rent per week at baseline Int/Cont £32.24/£31.00.
Mean change in rent per week Int/Cont +£6.65/+£1.31. Some residents reported increased fuel cost (Int/Cont 14/
5) actual cost data not presented.
Critchley et al, 2004, UK29 A Contr’d
B&A
✓ No Over 12-year period Liverpool Housing Action Trust invested £260 m in housing renewal (this appears to be the
total housing budget and does not refer specifically to this intervention). Estimated annual running costs Before
vs After rehousing for: two person household £662 vs £347; single person’s costs £610 vs £319. Percentage living
in fuel poverty(excluding housing benefit), Before vs After intervention for- 1 person households 86% vs 14%; 2
person households 48% vs 8%.
Thomas et al, 2005, UK28 65 B Contr’d
B&A
✓ Yes Total cost of renewal project (Single Regeneration Budget) £2 million over study period. Costs do not relate
necessarily to study sample and not specifically to housing, project included range of non-housing investment
improvements.
Blackman et al, 2001, UK30 66 C UBA ✓ Yes Mean cost of renewal project per house £8000. Total cost of housing renewal programme £5.5 million. Costs do
not relate necessarily to study sample and not specifically to housing, project included some environmental
improvements and road safety improvements.
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Table 2 Continued
Author, date, location
Study
quality
Study
design
Intervention
costs
Costs to
recipient
Potential for
economic evaluation Summary of economic data and accompanying authors’ interpretation
Ambrose, 2000, UK31 32 67 C UBA ✓ No Before vs 2 years After intervention. Mean weekly housing costs: rent (n=105 households) £52 vs £72; water
(n=60) £0.92 vs £4.38; gas (n=92) £5.54 vs £6.46; electricity (n=98) £4.62 vs £5.77. Before vs 3 years after
intervention (n=19 households): mean weekly housing costs: rent £60.33 vs £79.30; water £3.50 vs £5.06; gas
(n=9) £8.28 vs £6.15; electricity (n=6) £4.76 vs £3.33.
(cost data collected retrospectively, not all participants reporting cost data also reported health data)
Walker and Bradshaw, 1999
UK33
C XCBA ✓ ✓ No Investment of £8.6 million by local authority in repair of homes and renovation of property. Percentage change in
general practice prescribing costs per 1000 patients after intervention (1994–1998). Intervention practice A/
Intervention practice B/Control practices (n=7): gastrointestinal +12.33%/+25.8%/+12.92%; cardiovascular
+31.27%/+37.56%/+27.01%; respiratory +46.92%/+82.87%/+43.57+; central nervous system +79.22%/+73.7%/
+79.7%; hypnotic +67.58%/+15.99%/+93.33%; anxiolytic −74.12%/−12.29%/−6.51%; antidepressant
+109.51%/+86.27%/+120.77%; analgesic +26.92%/+26.59%/+42.66%; anti-infective +12.96%/−22.19%/
−26.26%.
Woodin et al, 1996, UK34 C R ✓ No Total cost of renewal project £97 million, figure includes more than study sample.
Halpern, 1995, UK35 C XUBA ✓ Yes Mean cost of intervention per house (full refurbishment) £10 000–£15 000.
Intervention: Provision of basic housing needs/low or middle income country
Cattaneo et al, 2006,
Mexico36
B RC ✓ Yes Mean cost of intervention per house=$(US)150.
Aga Khan Health Service,
2001, Pakistan38
B RC ✓ No Annual spending (rupees) on health care after intervention (Int/Cont n=50/99) 0 rupees=14%/16%; 1–999 rupees
18%/18%; 1000–5999 rupees 26%/39%; >5999 rupees 26%/16%; don’t know 16%/10%. Estimated that
insulation has resulted in up to 50% reduction in wood consumption by a typical family, reducing cost and time
spent collecting and buying firewood.
Aiga et al, 2002,
Phillipines37 68
C R ✓ No Mean monthly household expenditure on water (Pesos) Int/Cont 109/234. Intervention cost not available.
Mean household income (Pesos) after intervention Int/Cont 8032/4530. Increased household income attributed to
increase in time available to earn (as a result of improved water supply). Estimated that increased income of 5740
Pesos in control group if they received improved water supply.
Wolff et al, 2001, Malawi39 C UBA ✓ Yes Mean cost of building a new ‘habitat’ house, $ (US) 550.
Intervention: Rehousing from slums (pre-1965)
McGonigle et al, 1936 UK41 B Contr’d
B&A
✓ No Mean weekly rent Before vs After Int 4s.8d/9s.0d. Cont 4s.7¾d/4s.10¾d (s=shilling, d=pence, 1 shilling=5
pence). Rent as a % of income subdivided by employed or unemployed status (Int/Cont n=28/27 families). Int
Employed/unemployed 20.5%/31.3%; Cont Employed/unemployed 14.7%/20.8% (Int/Cont n=35/30 families)
Before vs After Int/Cont rent as % of income 20.5%/14.7% vs 31.3%/20.8%.
Chapin, 1938, USA40 C UBA ✓ ✓ No Mean cost of intervention per house $(US) 7791 total cost of project $3 623 000 for 465 houses.
Before vs After intervention, mean unit rental $(US) 15.68 vs 17.98, mean room rental $(US)3.21 vs 3.79.
*Study design: RCT, randomised controlled trial; Contr’d B&A, controlled before & after; UBA, uncontrolled before & after; XCBA, controlled before & after using area level cross sectional data at both time points; XUBA, uncontrolled before & after
using area level cross sectional data at both time points; RC, retrospective controlled study; R, retrospective uncontrolled.
QALY, quality adjusted life year.
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reduction following energyefﬁciency improvements.17 19 25 26 31 47
Each of the ﬁve studies which reported numerical data for
changes in rent reported increased rent following housing
improvement.26 27 31 40 41
Of the 25 studies which presented only cost data, 11 (8 from
the UK) were assessed to have sufﬁcient data for an economic
evaluation. Analysis linking cost data to health outcomes could
have been conducted to present a cost-effectiveness, cost-utility
or cost-beneﬁt analysis (table 2).16 20–23 26 28 30 35 36 39
Two studies, both from the UK, reported plans to conduct an
economic evaluation but this was either not conducted or not
publicly available at the time of this review. Neither of these
studies was among the 11 reporting data amenable to economic
evaluation; Eick et al24 did not have data for a comparator
group and Caldwell et al25 did not have data on intervention
costs. Eick et al24 presented data on medical costs before and
after the intervention and reported plans for a cost-beneﬁt ana-
lysis. Caldwell et al (2001) originally planned to examine issues
of cost-effectiveness but this was not undertaken due to poor
quality data.
Studies reporting an economic evaluation
Four studies reported undertaking an economic evaluation
(table 3). These studies all involved warmth and energy efﬁ-
ciency interventions since 2000 or later. Two studies were from
the UK44–46 and two from New Zealand.42 43 50 The methodo-
logical study quality, with respect to assessment of health
impacts in the original systematic review, varied; two studies
were assessed to have a minimal risk of bias (grade A),42 45 50
one study was assessed to have some risk of bias (grade B)44 46
and one study was assessed to have considerable potential for
bias (grade C).43
Three of these studies reported undertaking a cost-beneﬁt
analysis. These studies fall short of full cost-beneﬁt analysis, as
deﬁned above, as they did not include a monetary valuation of
all important outcomes. They are more accurately described as
having presented a ‘balance sheet’ type approach. This hybrid
approach involves identifying and listing the costs and beneﬁts
associated with an intervention or policy change, in much the
same way as in a cost-consequence study.7 51 52 The costs and
some of the beneﬁts are then measured in monetary units where
appropriate values are either available or can be postulated,
otherwise they are simply listed in their natural units (eg, time).
For example, a UK study44 presented cost data for medical treat-
ments, prescriptions and fuel use and imputed a monetary
beneﬁt of reduced school absences. A study from New
Zealand42 50 presented a beneﬁt-cost ratio based on the cost of
the intervention, changes in the costs of medical service use,
and the economic value imputed for reduced CO2 emissions
and the reduction in lost days of school and work. Another
study from New Zealand43 presented a feasibility study for a
cost-beneﬁt analysis with a direct beneﬁt to cost ratio, however
the authors provided no details of the methods used or the out-
comes measured. The ﬁndings from all three studies suggested
net economic beneﬁts associated with the interventions based
on the outcomes measured in monetary terms (ie, the monetary
value imputed for these outcomes exceeds the net costs of the
intervention less any costs savings achieved elsewhere). In add-
ition, both New Zealand studies indicate small, but positive,
beneﬁts to cost ratios associated with the intervention.42 43 50
One study reported undertaking a cost-effectiveness analysis
which met the criteria employed by this review.45 This UK study
used health indicator data (SF-36) to conduct a cost-
effectiveness analysis. Although data were not presented
numerically (it was narratively reported that the results were not
statistically signiﬁcant), a bootstrapped cost-effectiveness esti-
mate presented graphically suggested that the intervention was
dominated. This means that the intervention (improved
housing) was more costly and less effective than the status quo.
Additional studies
Two further economic studies of housing interventions were
identiﬁed when contacting study authors about completion of
ongoing housing studies which might contribute to an update of
the original housing review. These studies were published
recently and were not included in the original systematic
review.53 54 Edwards et al53 report an economic evaluation, as
deﬁned here, presenting an estimate of the additional cost per
point improvement on the PedsQL asthma speciﬁc scale. Grimes
et al54 present a ‘balance sheet’ approach with a calculation of
net economic beneﬁt.
In addition, we are aware of the economic evaluation under-
taken alongside the Scottish Housing and Regeneration Project
(submitted to JECH Lawson, Kearns, Petticrew, Fenwick,
Investing in health: is social housing value for money? A cost-
utility analysis.); however at the point at which our review was
undertaken, results for this analysis were not available.
DISCUSSION
Studies investigating the health impacts of housing improvement
have frequently provided some details on costs or economic
analysis (n=29/45).14 However, the majority of these (n=25/29)
present data on intervention and/or recipient costs only and,
despite sufﬁcient data, opportunities to conduct economic ana-
lysis have been missed. Where studies report conducting eco-
nomic evaluations, the majority of the reported analyses would
be more accurately described as a ‘balance sheet’ approach.
Findings from the studies which report costs only, suggest
that fuel costs may reduce following provision of warmth and
energy efﬁciency improvements, and that rents may increase fol-
lowing housing improvement. These ﬁndings need careful inter-
pretation. Changes in fuel costs are largely dictated by the unit
cost of fuel and may not be directly linked to changes in fuel
use or levels of warmth. In addition, changes in housing costs to
recipients, including rent and fuel, may be mediated by welfare
provision and changes in the individual’s eligibility for welfare
beneﬁts such as housing beneﬁt. As such, neither of these
changes can necessarily be taken to indicate an improvement, or
not, for the recipient of the intervention.
The three studies which presented a ‘balance-sheet’ approach
reported a positive net economic beneﬁt following the interven-
tion, based on the outcomes valued in monetary terms.42–44 50
One cost-effectiveness study45 reported that the intervention
was more costly and less effective, in terms of SF-36 score, than
the status quo,45 indicating that the intervention was not cost-
effective. This may reﬂect the fact that mental and physical
health (measured by SF-36) deteriorated following housing
improvement; or, and perhaps more likely, that the disruption
during housing upgrading led to deterioration in health out-
comes and the relatively short period of follow-up (maximum
of two years) failed to capture the longer term impacts of the
intervention.
The absence of long term health impacts limits the potential
for economic analysis. The longest follow-up in this group of
studies was 3.5 years after the intervention (range 1 month to
3.5 years). Expectations that health impacts will be observed in
this short timescale may be naive and it may be more realistic to
hypothesise that the potential for health beneﬁts could be many
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Table 3 Housing improvement studies reporting an economic evaluation (ordered by intervention type, study quality and date)
Author, date,
location Description of housing intervention
Study
design
Summary of effect directions on health
outcomes by domain**
Summary of economic data and analysis reported
General
health Respiratory
Mental
health
Illness/
symptom
Intervention: Warmth and energy efficiency improvements (post-1980)
Barton et al, 2007,
UK31 45 69
Upgrading heating provision and energy efficiency according
to need. For some houses, roofs were fitted with breathable
roofing felt, plus 50 mm insulation, Cavity insulation with
rockwool fibres, and double glazing. Over ceiling insulation
topped up to 200 mm (glass fibre quilting), Front and back
doors and French windows were replaced with uPVC doors.
RCT <> ◄► <> ▾ Paper states cost effectiveness analysis was carried out using
SF-36 data, and report no significant differences between
groups or over time in SF-36 subscales, but no data reported.
Bootstrapped cost-effectiveness estimate (presented
graphically) suggests that intervention dominated (more
costly, less effective).
Costs of intervention for each year. 49 houses improved in
1999, cost per house of £7760, 63 houses improved in 2000,
average cost per house of £4819
Compares costs (£GBP) between intervention and control groups for 3 years
Costs per person (Year 1999) Intervention Control
Annual equivalent intervention costs net of annual energy
saving
£0 £0
All NHS costs* £204.86 £220.49
Benefits
SF36 (adults) 0.73 0.75
Value of lost education £240.7 £288.44
Costs per person (Year 2000) Intervention Control
Annual equivalent intervention costs net of annual energy
saving
£-18.82 £0
All NHS costs* £224.97 £171.54
Benefits
SF36 (adults) 0.77 0.8
Value of lost education £352.28 £247.59
Costs per person (Year 2001) Intervention Control
Annual equivalent intervention costs net of annual energy
saving
£0 £-16.56
All NHS costs* £135.72 £165.56
Benefits
SF36 (adults) 0.72 0.8
Value of lost education £80.92 £169.92
Chapman et al, 2007,
New
Zealand42 50 70 71
Ceiling insulation, draught-proofing of windows and doors,
sisalated paper (insulated foil) strapped under floor joists,
and polyethylene covering over the ground.
RCT ▴ ▴ ▴ Cost of intervention per household was $(NZ)1800. Assumed lifetime of benefits is
30 years
Economic value of benefits ($(NZ)).
Change in GP visits 165*
Reduced hospital admissions 2231
Reduced days of school 242
Reduced days of work 179
Energy savings 786
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Table 3 Continued
Author, date,
location Description of housing intervention
Study
design
Summary of effect directions on health
outcomes by domain**
Summary of economic data and analysis reported
General
health Respiratory
Mental
health
Illness/
symptom
CO2 savings 100
Total savings 3374
* negative saving
Calculated per household: savings $NZ 3374; intervention cost $NZ1800. Net benefit
of $1574 per household. Benefit-cost ratio of 1.87:1 Estimated value of savings was
around $NZ 25 a year.
Mackenzie et al, 2000,
UK44 46
Grant up to £2500 to improve heating and reduce damp and
mould growth in house, intervention agreed according to
need. (Gas central heating, n=28 (47%), electric storage
heater, n=22 (37%), solid fuel central heating, n=7 (12%),
oil-fired central heating, n=2 (4%)).
UBA ▴ Average cost of intervention £3061 per house
Data on health service contacts and prescribing data (before and after intervention)
available for 47 children (48% 47/97 invited to take part)
Costs estimated for NHS contacts and prescriptions and school absences.
Annual equivalent cost of improvements £329.49
Less
Estimated annual saving on fuel bills 214.81
Est. annual saving on NHS treatment costs £499.54
Est. annual increase in prescribing costs −£11.41
Est. annual value of increased school att. £108.36
Total estimated benefits from home improve £810.23
Net benefit per annum £413.33
Laing and Baker,
2006, New
Zealand43 72–74
Insulation (26.5%) & ventilation (43.5%) improvements,
improved heating system (4.4%), extensions (8.7%), plus
housing and health advice, improved links with health and
other support agencies
RC No health impacts only service use In house cost benefit analysis
Direct benefit to cost ratio −0.87 net present value to household, $(AUS)2222; when
some indirect benefits included benefit to cost ratio 1.15 and net present value to
household of $(AUS)2471
No detail of methods or outcomes measures for analysis are provided. CBA planned
*Study design: RCT, randomised controlled trial; CBA, controlled before & after; UBA, uncontrolled before & after; RC, retrospective controlled study.
**Effect direction: upward arrow, positive health impact; downward arrow, negative health impact; sideways arrow, no change/mixed effects/conflicting findings.
Sample size: final sample size (individuals) in intervention group: large arrow, >300; medium arrow, 50–300; small arrow, <50.
Statistical significance: black arrow, p<0.05; grey arrow, p>0.05; empty arrow, no statistics/data reported.
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years after the intervention, perhaps only in the next generation
of residents. A full economic evaluation should ideally consider
the impacts over the lifetime of the intervention. However,
attributing longer term impacts to a historical intervention, even
in large scale datasets with minimal attrition, introduces an add-
itional level of confounding. Uncertainty due to immeasurable
confounding is an important issue even for short term studies.
As such, data on longer term health impacts may be useful but
requires careful interpretation.55
The near absence of economic evaluation of housing improve-
ments cannot solely be explained by difﬁculties in collecting
suitable data. Over 40% of the studies which presented cost
data alone, had sufﬁcient data to conduct an economic evalu-
ation, but had not done so. This comparative data on costs and
health outcome for the intervention and status quo could have
been presented to provide a measure of value for money of the
intervention, for example in terms of the additional cost per
unit of effectiveness achieved. The speciﬁc form of the evalu-
ation would depend on the measure of health outcome collected
with data such as SF-36, EQ-5D, etc used to determine QALYs
for a cost-utility analysis, monetary values of health outcome
used within a cost-beneﬁt analysis and other measures of health/
clinical outcome used within a cost-effectiveness analysis (see
table 1). Where economic analysis was conducted, most (n=3/4)
of the studies claimed to have undertaken a cost-beneﬁt analysis
but had in fact presented a ‘balance sheet’ approach. This
hybrid approach can be helpful for policy-makers by identifying
the costs and outcomes associated with a policy/intervention
and who bears/receives these impacts.7 51
In each of these three studies, the authors calculated the net
economic beneﬁts associated with the interventions of interest, as
required to establish value for money in a full cost-beneﬁt ana-
lysis. However, none of these studies included changes to health
outcomes within the beneﬁts assessment in their calculation,
despite all three collecting data on health outcomes. As such,
none of these studies provides a full monetary assessment of the
beneﬁts associated with the interventions of interest. Instead the
economic beneﬁts calculation was restricted to a monetary valu-
ation for increased school and/or work attendance and reduc-
tions in CO2 emissions. All three included changes in health
service utilisation within the calculation, although these cost
changes were frequently misreported as beneﬁts.
These results suggest three important factors. First, the import-
ance of and need for collecting data over a reasonable period of
follow-up to allow detection of long term health improvements.
Second, the importance of employing wider perspectives through
inclusion of costs and savings in other sectors (eg, education or
the environment) to give greater potential to show cost offsets
and/or cost-effectiveness of housing interventions. Third, and
perhaps most importantly, a lack of familiarity with the techni-
ques of economic evaluation such that studies with relevant data
often fail to make best use of it, while other studies fail to collect
relevant data or misrepresent analyses that are undertaken.
CONCLUSIONS AND LESSONS FOR THE FUTURE
Rigorous economic evaluation of public health interventions,
including those in housing, is seen as a priority. Future studies
planning an economic evaluation need to make best use of all
available data as well as ensuring that all relevant data are col-
lected. To facilitate this, economic evaluations should be
planned alongside the intervention with health economists
included from the outset. When undertaken appropriately, eco-
nomic evaluation provides the potential to make a signiﬁcant
contribution to healthy housing policy.
What is already known on this subject
▸ Economic evaluation assessing the costs and health beneﬁts
of healthy public policy interventions has been advocated
but has rarely been undertaken.
▸ Housing investment represents a substantial policy
investment area which is considered to have potential to
contribute to a wider public health strategy to improve
population health and reduce health inequalities.
▸ Some studies assessing the health impact of housing
improvement have reported some data on costs and
economic analysis.
▸ Examination of the nature of cost data and economic
analysis reported in these studies may help to explain why
economic evaluation has rarely been conducted and provide
tangible examples of the potential to develop economic
evaluation of healthy public policy investment.
What this study adds
▸ Despite availability of cost data, opportunities to conduct
economic evaluations of housing interventions have often
been missed.
▸ A small number of studies have reported ‘economic
evaluation’ but the term has often been misappropriated.
▸ Future studies planning an economic evaluation should ensure
that it is planned alongside the intervention to ensure that all
relevant data are collected and available data are fully utilised.
▸ Studies should include a health economist from the outset.
Policy implications
▸ Increasingly policy-makers, seeking to spend money from
limited budgets, want evidence of value for money
associated with changes in public policy.
▸ Appropriately conducted economic evaluations have the
potential to identify public policies which represent good
value for money.
▸ Existing economic analyses of the health impacts of housing
improvement have often fallen short of undertaking
economic evaluations.
▸ Improved planning and better use of available data should
ensure that economic evaluations are undertaken which can
provide policy-makers with the evidence they require.
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